| Product Name | ORAOV1 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ORAOV1 antibody; TAOS1 antibody; Oral cancer-overexpressed protein 1 antibody; Tumor-amplified and overexpressed sequence 1 antibody; |
| Product description | miscellaneous:Amplified and overexpressed in oral cancer cells. Belongs to the ORAOV1 family. tissue specificity:Widely expressed. Highly expressed in placenta, kidney and skeletal muscle. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human ORAV1. AA range:81-130 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHCIF |
| WB:1:500-1:2000 IHC:1:100-1:300 IF:1:100-1:500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | ORAOV1 antibody TAOS1 antibody Oral cancer-overexpressed protein 1 antibody Tumor-amplified and overexpressed sequence 1 antibody |
|---|---|
| Molecular Weight(MW) | 15 kDa |
| SwissProt ID | Q8WV07 |
|---|
| Positive Control | Melanoma,Pancreatic carcinoma, |
|---|---|
| Application Notes | WB:1:500-1:2000 IHC:1:100-1:300 IF:1:100-1:500 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
